1. Home
  2. CMPS vs EMD Comparison

CMPS vs EMD Comparison

Compare CMPS & EMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMPS
  • EMD
  • Stock Information
  • Founded
  • CMPS 2020
  • EMD 2003
  • Country
  • CMPS United Kingdom
  • EMD United States
  • Employees
  • CMPS N/A
  • EMD N/A
  • Industry
  • CMPS Biotechnology: Pharmaceutical Preparations
  • EMD Finance/Investors Services
  • Sector
  • CMPS Health Care
  • EMD Finance
  • Exchange
  • CMPS Nasdaq
  • EMD Nasdaq
  • Market Cap
  • CMPS 598.7M
  • EMD 599.9M
  • IPO Year
  • CMPS 2020
  • EMD N/A
  • Fundamental
  • Price
  • CMPS $5.31
  • EMD $10.43
  • Analyst Decision
  • CMPS Strong Buy
  • EMD
  • Analyst Count
  • CMPS 8
  • EMD 0
  • Target Price
  • CMPS $16.43
  • EMD N/A
  • AVG Volume (30 Days)
  • CMPS 2.1M
  • EMD 248.5K
  • Earning Date
  • CMPS 11-04-2025
  • EMD 01-01-0001
  • Dividend Yield
  • CMPS N/A
  • EMD 10.25%
  • EPS Growth
  • CMPS N/A
  • EMD N/A
  • EPS
  • CMPS N/A
  • EMD N/A
  • Revenue
  • CMPS N/A
  • EMD N/A
  • Revenue This Year
  • CMPS N/A
  • EMD N/A
  • Revenue Next Year
  • CMPS N/A
  • EMD N/A
  • P/E Ratio
  • CMPS N/A
  • EMD N/A
  • Revenue Growth
  • CMPS N/A
  • EMD N/A
  • 52 Week Low
  • CMPS $2.25
  • EMD $7.85
  • 52 Week High
  • CMPS $7.09
  • EMD $9.55
  • Technical
  • Relative Strength Index (RSI)
  • CMPS 41.21
  • EMD 49.19
  • Support Level
  • CMPS $5.01
  • EMD $10.35
  • Resistance Level
  • CMPS $6.01
  • EMD $10.66
  • Average True Range (ATR)
  • CMPS 0.47
  • EMD 0.13
  • MACD
  • CMPS -0.09
  • EMD -0.01
  • Stochastic Oscillator
  • CMPS 15.78
  • EMD 43.59

About CMPS COMPASS Pathways Plc American Depository Shares

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

About EMD Western Asset Emerging Markets Debt Fund Inc

Western Asset Emg Markets Debt Fund Inc is a non-diversified closed-end management, and long term investment company. The primary investment objective of the company is to seek high current income and the secondary objective is to seek capital appreciation.

Share on Social Networks: